发明名称 |
Enhanced bimatoprost ophthalmic solution |
摘要 |
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein. |
申请公布号 |
US9155716(B2) |
申请公布日期 |
2015.10.13 |
申请号 |
US201313826047 |
申请日期 |
2013.03.14 |
申请人 |
Allergan, Inc. |
发明人 |
Chang Chin-Ming;Chang James N.;Schiffman Rhett M.;Jordan R. Scott;Chang-Lin Joan-En |
分类号 |
A61K31/164;A61K9/00;A61K9/08;A61K31/14;A61K31/5575;A61K47/18;A61K31/165 |
主分类号 |
A61K31/164 |
代理机构 |
|
代理人 |
Siddiqi Lorenz |
主权项 |
1. A method of lowering intraocular pressure in a person with glaucoma or ocular hypertension, the method comprising administering once daily to an eye of the person a first composition comprising about 0.01% w/v bimatoprost and about 0.02% w/v benzalkonium chloride, wherein the method lowers intraocular pressure as effectively and results in improved ocular surface tolerability as compared to the once daily administration of a second composition comprising 0.03% w/v bimatoprost and 0.005% w/v benzalkonium chloride. |
地址 |
Irvine CA US |